| Literature DB >> 33103626 |
Peter Franz Klein-Weigel1, Saban Elitok2, Andreas Ruttloff1, Sabine Reinhold1, Jessika Nielitz1, Julia Steindl1, Birgit Hillner3, Lars Rehmenklau-Bremer3, Christian Wrase4, Heiko Fuchs4, Thomas Herold3, Lukas Beyer4.
Abstract
The superior vena cava syndrome (SVCS) is caused by compression, invasion, and/or thrombosis of the superior vena cava and/or the brachiocephalic veins. Benign SVCS is separated from malignant SVCS. SVCS comprises a broad clinical spectrum reaching from asymptomatic cases to rare life-threatening emergencies with upper airway obstruction and increased intracranial pressure. Symptoms are correlated to the acuity and extent of the venous obstruction and inversely correlated to the development of the venous collateral circuits. Imaging is necessary to determine the exact underlying cause and to guide further interventions. Interventional therapy has widely changed the therapeutic approach in symptomatic patients. This article provides an overview over this complex syndrome and focuses on interventional therapeutic methods and results.Entities:
Keywords: superior vena cava syndrome; superior vena cava thrombosis; thrombaspiration; thrombolysis; tumor compression; venous stenting
Mesh:
Year: 2020 PMID: 33103626 DOI: 10.1024/0301-1526/a000908
Source DB: PubMed Journal: Vasa ISSN: 0301-1526 Impact factor: 1.961